Please provide your email address to receive an email when new articles are posted on . An analysis of registry data from the United Network for Organ Sharing suggests that human leukocyte antigen ...

Only 30% of patients in need of allo-HSCT will have a suitable human leukocyte antigen (HLA)-matched family member, and in the remainder an unrelated donor (UD) may be sought. 12 Although studies on ...

Allogeneic haematopoietic cell transplantation (HCT) is a potentially curative treatment for both malignant and non-malignant hematologic disease, as well as some immunologic and metabolic disorders.

HLA testing has been a staple in transplantation since the recognition that antibodies, directed against lymphocytes, were associated with allograft failure. This seminal finding led to the discovery ...

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use ...

"Histo" means "tissue." Histocompatibility is defined as a measure of how well 2 tissues "get along with one another" when they find themselves in a confined space. The major physiologic barrier in ...

BLEAT is designed to work in three parts. Firstly, it is required to input the transplant recipient’s HLA-B typing information into the software, alongside HLA-B typing information for any potential ...

To the Editor: Petersdorf et al. (Dec. 20 issue) 1 suggest that for patients with chronic myelogenous leukemia for whom a donor with an HLA class I mismatch cannot be avoided, “the preferred . . .

Please provide your email address to receive an email when new articles are posted on . For years, hematopoietic stem cell transplantation physicians have viewed a matched unrelated donor as the gold ...

Here’s a scenario: you’ve recently been diagnosed with leukemia and find yourself needing a blood stem cell transplant (or, in scientific parlance, a hematopoietic stem cell transplant, HSCT) as part ...